SCNX Scienture Holdings, Inc.
Healthcare$0.40-0.50%ClosedMarket Cap: $6.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
12.97
EV/EBITDA
89.06
DCF Value
$41.87
FCF Yield
-47278.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-17.4%
Operating Margin
-3230.0%
Net Margin
-8761.3%
ROE
-0.1%
ROA
-0.1%
ROIC
-0.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $56.3K | -735.3% | $-3.5M | $-3.4M | $— | — |
| Q4 null | $-168.7K | 144.5% | $-3.2M | $-28.1M | $— | — |
| FY null | $431.6K | 76.8% | $-16.2M | $-41.5M | $— | — |
| Q3 null | $590.0K | 97.4% | $-3.6M | $-3.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.2M | $-6.7M | $— | — |
| Q1 null | $10.3K | 6.6% | $-3.6M | $-3.1M | $— | — |
| Q4 null | $53.1K | 5.3% | $-4.2M | $-7.2M | $— | — |
| FY null | $136.6K | 4.4% | $-14.7M | $9.1M | $— | $9.50 |
| Q3 null | $64.9K | 6.0% | $-3.5M | $-3.2M | $— | $1.50 |
| Q2 null | $18.7K | -3.8% | $-1.5M | $-1.8M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-5.5M | $-8.4M | $— | $8.00 |
| Q4 2023 | $2.4M | -95.6% | $-6.2M | $-11.7M | $-4.93 | — |